tiprankstipranks
Trending News
More News >
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
US Market
Advertisement

Crispr Therapeutics AG (CRSP) Technical Analysis

Compare
9,825 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
3Neutral
4Bearish
Technical Analysis Consensus
Sell
3Bullish
3Neutral
4Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Crispr Therapeutics AG’s (CRSP) Moving Averages Convergence Divergence (MACD) indicator is 5.16, suggesting Crispr Therapeutics AG is a Sell.
Crispr Therapeutics AG’s (CRSP) 20-Day exponential moving average is 55.17, while Crispr Therapeutics AG’s (CRSP) share price is $65.93, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 50-Day exponential moving average is 48.46, while Crispr Therapeutics AG’s (CRSP) share price is $65.93, making it a Buy.

Crispr Therapeutics AG (CRSP) Pivot Points

Jul 24, 2025, 05:34 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
56.86
60.88
63.10
67.12
69.34
73.36
75.58
Fibonacci
60.88
63.26
64.73
67.12
69.50
70.97
73.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Crispr Therapeutics AG (CRSP) Moving Averages

Jul 24, 2025, 05:34 AM
Period
Simple
Exponential
MA5
61.32Buy
62.48Buy
MA10
59.16Buy
59.39Buy
MA20
54.36Buy
55.17Buy
MA50
45.34Buy
48.46Buy
MA100
42.08Buy
45.14Buy
MA200
43.85Buy
45.44Buy
Crispr Therapeutics AG’s (CRSP) 10-Day exponential moving average is 59.39, while Crispr Therapeutics AG’s (CRSP) share price is $65.93, making it a Buy.
Crispr Therapeutics AG’s (CRSP) 100-Day exponential moving average is 45.14, while Crispr Therapeutics AG’s (CRSP) share price is $65.93, making it a Buy.
Crispr Therapeutics AG’s (CRSP) stock price is $65.93 and Crispr Therapeutics AG’s (CRSP) 50-day simple moving average is 45.34, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $65.93 and Crispr Therapeutics AG’s (CRSP) 100-day simple moving average is 42.08, creating a Buy signal.
Crispr Therapeutics AG’s (CRSP) stock price is $65.93 and Crispr Therapeutics AG’s (CRSP) 200-day simple moving average is 43.85, creating a Buy signal.

Crispr Therapeutics AG (CRSP) Technical Indicators

Jul 24, 2025, 05:34 AM
Name
Value
Implied Action
RSI (14)
76.28
Sell
STOCH (9,6)
77.54
Neutral
STOCHRSI (14)
82.31
Sell
MACD (12,26)
5.16
Sell
ADX (14)
44.27
Neutral
Williams %R
-22.60
Buy
CCI (14)
141.61
Sell
ATR (14)
3.82
-
Ultimate Oscillator
59.40
Neutral
ROC
35.91
Buy
Crispr Therapeutics AG’s (CRSP) Relative Strength Index (RSI) is 76.28, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) Trend Strength Indicator (ADX) is 44.27, creating a Neutral signal.
Crispr Therapeutics AG’s (CRSP) Commodity Channel Index (CCI) is 141.61, creating a Sell signal.
Crispr Therapeutics AG’s (CRSP) Price Rate of Change (ROC) is 35.91, creating a Buy signal.

FAQ

Is CRSP a Buy, Hold, or Sell?
Based on CRSP’s technical indicators, CRSP is a Buy.
    What is CRSP’s RSI (14)?
    CRSP’s RSI (14) is 76.28, which suggests CRSP is a Sell.
      What is CRSP’s MACD?
      CRSP’s MACD is 5.16, which suggests CRSP is a Sell.
        What is CRSP’s 5-day moving average?
        CRSP’s 5-day moving average is 61.32, which suggests CRSP is a Buy.
          What is CRSP’s 20-day moving average?
          CRSP 20-day moving average is 54.36, which suggests CRSP is a Buy.
            What is CRSP’s 50-day moving average?
            CRSP’s 50-day moving average is 45.34, which suggests CRSP is a Buy.
              What is CRSP’s 200-day moving average?
              CRSP’s 200-day moving average is 43.85, which suggests CRSP is a Buy.
                What is CRSP’s Williams % R (14)?
                CRSP’s Williams % R (14) is -22.60, which suggests CRSP is a Buy.
                  What is CRSP’s CCI (14)?
                  CRSP’s CCI (14) is 141.61, which suggests CRSP is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis